Design, Evaluation and Study of Effect of Hydrophilic Polymers on Release Rate of Antiulcer Floating Tablets

ABSTRACT

Gastro retentive drug delivery systems are the systems which are retained in the stomach for a longer period of time and thereby improve the bioavailability of drugs. Different approaches for gastro retentive dosage forms include ß oating, raft, expanding/swelling, bioadhesive/ mucoadhesive and high/low density systems.Famotidine, an anti-ulcer drug, suffers from poor bioavailability (50% as famotidine is less soluble in alkaline pH. Famotidine used in combination with antacids promotes local delivery of these drugs to the receptor of the parietal cell wall. Local delivery also increases bioavailability at the stomach wall receptor site and increases the efÞ cacy of drugs to reduce acid secretion. This study aim to formulate ß oating tablets of famotidine using an effervescent approach for gastroretentive drug delivery system. Floating tablets were prepared using direct compression techniques using polymers like HPMC K4M and HPMCK100M for their gel-forming properties. The HPMC polymer alone is unable to control release rate. It releases drug >90% in four to six hours. In combination with Xanthan gum it release >90% in eight hours. The results indicate that gas generated gastroretentive ß oating tablets of famotidine containing HPMCK100M and Xanthan gum provide better options for controlled release action and improved bioavailability.

KEYWORDS

• Famotidine
• HPMC K4M
• HPMC K100M
• xanthan gum
• swelling index

Showing references and in-text citations exactly as published.

• DOI10.4103/0975-1483.59318Copy

RELATED ARTICLES

Matched on section and article type within this issue of JYP.

• Article · VOLUME 1, ISSUE 4Effect of Permeation Enhancers on the Release and Permeation Kinetics of Oxytetracycline Hydrochloride Organogel FormulationsNandini D, Chauhan NS, Chandra A, Pathak K · pp. 285–289PharmaceuticsSame type: Article
• Article · VOLUME 1, ISSUE 4Microdosing vs. Therapeutic Dosing for Evaluation of Pharmacokinetic Data: A Comparative StudyMahajan R, Parvez A, Gupta K · pp. 290–294PharmaceuticsSame type: Article
• Article · VOLUME 1, ISSUE 4Advanced PEGylation for the Development of Raloxifene Hydrochloride, BCS Class II DrugBandela JJ, Anupama CH · pp. 295–300PharmaceuticsSame type: Article
• Article · VOLUME 1, ISSUE 4Development and Evaluation of Sustained Delivery of Diclofenac Sodium from Hydrophilic Polymeric BeadsDhanaraju MD, Sundar VD, NandhaKumar S, Bhaskar K · pp. 301–304PharmaceuticsSame type: Article